1. A retrospective analysis of peripheral T-cell lymphoma patients: single-center 'real-life' experience. (October 2019) Authors: Ozbalak, M.; Kalayoglu Besisik, S.; Mastanzade, M. Guzel; Ozluk, O.; Ozmen, A.; Hindilerden, I. Yonal; Yenerel, M.; Nalcaci, M. Journal: Leukemia research Issue: Volume 85(2019)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey. (June 2017) Authors: Ferhanoglu, B.; Bekoz, H.; Karadurmus, N.; Paydas, S.; Gulbas, Z.; Turker, A.; Toptas, T.; Firatli Tuglular, T.; Tekgunduz, E.; Kaya, A.; Tastemir, N.; Arat, M.; Pepedil Tanrikulu, F.; Ozkocaman, V.; Abali, H.; Turgut, M.; Kaynar, L.; Karadogan, I.; Ozbalak, M.; Dogu, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1620: RED CELL ALLOIMMUNIZATION IN MULTI-TRANSFUSED TURKISH PATIENTS WITH HEMATOLOGIC DISORDERS. (23rd June 2022) Authors: Oztaskin, S.; Yanasik, M.; Ozbalak, M.; Guzel Mastanzade, M.; Ozluk, O.; Tiryaki, T. O.; Erdem, S.; Besisik, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗